Qun Liu, Song-Min Wang, Xuan Chen, Yi-Rao You, Chen-Jiao Guo, Chang-Qin Xie, Lu-Lu Wang, Qi Liu, Lan Zhang, Jun-Tao Yang
{"title":"Chrysin attenuates diabetes-induced retinal injury by inhibiting microglial GBP3/NLRP3/GSDMD-mediated pyroptosis.","authors":"Qun Liu, Song-Min Wang, Xuan Chen, Yi-Rao You, Chen-Jiao Guo, Chang-Qin Xie, Lu-Lu Wang, Qi Liu, Lan Zhang, Jun-Tao Yang","doi":"10.1002/ame2.70293","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study was designed to investigate whether chrysin, a natural flavone, alleviates experimental diabetic retinal disease and to define a microglia-centered mechanism involving guanylate-binding protein 3 (GBP3) and NLR family pyrin domain containing 3 (NLRP3)-gasdermin D (GSDMD) pyroptosis signaling.</p><p><strong>Methods: </strong>Streptozotocin (STZ)-diabetic mice received vehicle or chrysin for 4 weeks, followed by assessment of fasting blood glucose, serum caspase-1 and interleukin-1β (IL-1β) levels, retinal histology, Evans blue leakage, and retinal immunofluorescence for glial fibrillary acidic protein (GFAP) and ionized calcium-binding adaptor molecule 1 (IBA-1), with apoptosis measured by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL). In vitro, BV2 microglia were exposed to high glucose with vehicle or chrysin. Cell viability (Cell Counting Kit-8), oxidative stress (reactive oxygen species and malondialdehyde), and pyroptosis-associated markers were analyzed by Western blotting, reverse transcription quantitative polymerase chain reaction (RT-qPCR), and immunofluorescence. RNA sequencing (RNA-seq) profiled transcriptional responses, and small interfering RNA (siRNA) was used to knock down GBP3.</p><p><strong>Results: </strong>In STZ-diabetic mice, chrysin reduced fasting glucose and circulating caspase-1 and IL-1β, partially preserved retinal thickness, and decreased vascular leakage. Chrysin attenuated GFAP upregulation, reduced IBA-1 signals, and lowered TUNEL-positive cells. In BV2 cells, chrysin improved viability, reduced oxidative stress, and suppressed NLRP3-GSDMD activation. RNA-seq highlighted chrysin-responsive pyroptosis signatures and identified GBP3 as a regulated node. GBP3 knockdown reduced high-glucose-associated NLRP3 and Gsdmd expression and diminished GSDMD cleavage.</p><p><strong>Conclusions: </strong>Chrysin protects the diabetic retina and suppresses microglial pyroptosis via a GBP3-linked NLRP3-GSDMD axis.</p>","PeriodicalId":93869,"journal":{"name":"Animal models and experimental medicine","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13602009/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Animal models and experimental medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/ame2.70293","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 0
Abstract
Background: This study was designed to investigate whether chrysin, a natural flavone, alleviates experimental diabetic retinal disease and to define a microglia-centered mechanism involving guanylate-binding protein 3 (GBP3) and NLR family pyrin domain containing 3 (NLRP3)-gasdermin D (GSDMD) pyroptosis signaling.
Methods: Streptozotocin (STZ)-diabetic mice received vehicle or chrysin for 4 weeks, followed by assessment of fasting blood glucose, serum caspase-1 and interleukin-1β (IL-1β) levels, retinal histology, Evans blue leakage, and retinal immunofluorescence for glial fibrillary acidic protein (GFAP) and ionized calcium-binding adaptor molecule 1 (IBA-1), with apoptosis measured by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL). In vitro, BV2 microglia were exposed to high glucose with vehicle or chrysin. Cell viability (Cell Counting Kit-8), oxidative stress (reactive oxygen species and malondialdehyde), and pyroptosis-associated markers were analyzed by Western blotting, reverse transcription quantitative polymerase chain reaction (RT-qPCR), and immunofluorescence. RNA sequencing (RNA-seq) profiled transcriptional responses, and small interfering RNA (siRNA) was used to knock down GBP3.
Results: In STZ-diabetic mice, chrysin reduced fasting glucose and circulating caspase-1 and IL-1β, partially preserved retinal thickness, and decreased vascular leakage. Chrysin attenuated GFAP upregulation, reduced IBA-1 signals, and lowered TUNEL-positive cells. In BV2 cells, chrysin improved viability, reduced oxidative stress, and suppressed NLRP3-GSDMD activation. RNA-seq highlighted chrysin-responsive pyroptosis signatures and identified GBP3 as a regulated node. GBP3 knockdown reduced high-glucose-associated NLRP3 and Gsdmd expression and diminished GSDMD cleavage.
Conclusions: Chrysin protects the diabetic retina and suppresses microglial pyroptosis via a GBP3-linked NLRP3-GSDMD axis.